Can-Fite Biopharma

10 Bareket Street
Kiryat Matalon, P.O. Box 7537, Petah-Tikva 49170 ISRAEL
Click for website

Research Sector

Summary Description Biopharmaceutical company focused on autoimmune-inflammatory and cancer diseases.

Management Pnina Fishman, Ph.D., CEO; Motti Farbstein, CFO; Barak Singer, VP Business Development

Click here for Financial Data
Keywords: autoimmune diseases, inflammatory disease, cancer, oncology,


Updated: Mar. 21, 2016


Can-Fite BioPharma (TASE:CFBI; OTC:CANFY) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipe......view more

Products / Services

Drug products: CF101 CF102 CF602......view more

Technology / Differentiation

The company technology platform is based on the finding that the Gi protein coupled A3 adenosine Technology Platform - A3Areceptor (A3AR) is highly expressed in inflammatory and cancer cells whereas l...view more

Market / Customers

Cancer; autoimmune inflammatory diseases......view more

Revenue / Funding

N/A...view more